Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion

Matthias Manne Knopp; Johan Wendelboe; Rene Holm; Thomas Rades

doi:10.1016/j.ejpb.2018.07.005

Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion

Matthias Manne Knopp, Johan Wendelboe, Rene Holm, Thomas Rades

22 Citations (Scopus)

Original language	English
Journal	European Journal of Pharmaceutics and Biopharmaceutics
Volume	130
Pages (from-to)	290-295
ISSN	0939-6411
DOIs	https://doi.org/10.1016/j.ejpb.2018.07.005
Publication status	Published - Sept 2018

Keywords

Amorphous solid dispersion
Bioavailability
Phase separation
Crystallization
IVIVC

Access to Document

10.1016/j.ejpb.2018.07.005

Cite this

Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion. / Knopp, Matthias Manne; Wendelboe, Johan; Holm, Rene et al.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 130, 09.2018, p. 290-295.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{2924eeb6461f4b74bb5ba225130ecad8,

title = "Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion",

keywords = "Amorphous solid dispersion, Bioavailability, Phase separation, Crystallization, IVIVC",

author = "Knopp, {Matthias Manne} and Johan Wendelboe and Rene Holm and Thomas Rades",

year = "2018",

month = sep,

doi = "10.1016/j.ejpb.2018.07.005",

language = "English",

volume = "130",

pages = "290--295",

journal = "European Journal of Pharmaceutics and Biopharmaceutics",

issn = "0939-6411",

publisher = "Elsevier",

}

TY - JOUR

T1 - Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion

AU - Knopp, Matthias Manne

AU - Wendelboe, Johan

AU - Holm, Rene

AU - Rades, Thomas

PY - 2018/9

Y1 - 2018/9

KW - Amorphous solid dispersion

KW - Bioavailability

KW - Phase separation

KW - Crystallization

KW - IVIVC

U2 - 10.1016/j.ejpb.2018.07.005

DO - 10.1016/j.ejpb.2018.07.005

M3 - Journal article

C2 - 30064702

SN - 0939-6411

VL - 130

SP - 290

EP - 295

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

ER -

Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion

Keywords

Access to Document

Fingerprint

Cite this